JAK Inhibitors for Alopecia Areata
Dr. Antonella Tosti discusses the FDA’s first drug treatment approved for alopecia areata, JAK inhibitor baricitinib, as well as two JAK inhibitors that have filed with the FDA for the indication. Antonella Tosti, MD, Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida “This year has […]
Seborrheic Dermatitis: Unmet Needs and Innovations
Seborrheic dermatitis is a common inflammatory skin disease with underappreciated impacts on patient quality of life. In part 2 of this educational series on innovations in topical treatments for inflammatory skin disorders, Dr. Raj Chovatiya discusses the pathophysiology, clinical presentation, and limitations of current therapies for treating seborrheic dermatitis. About this Series This 3-part educational […]